K. Kluivers, I. Riphagen, M. Vierhout, H. Brolmann, and H. De-vet, Systematic review on recovery specific quality-of-life instruments, Surgery, vol.143, issue.2, pp.206-215, 2008.
DOI : 10.1016/j.surg.2007.08.017

M. Schumacher, M. Olschewski, and G. Schulgen, Assessment of quality of life in clinical trials, Statistics in Medicine, vol.34, issue.12, pp.1915-1930, 1991.
DOI : 10.1002/sim.4780101207

A. Leplege and S. Hunt, The Problem of Quality of Life in Medicine, JAMA: The Journal of the American Medical Association, vol.278, issue.1, pp.47-50, 1997.
DOI : 10.1001/jama.1997.03550010061041

S. Kong and S. Gandhi, Methodologic Assessments of Quality of Life Measures in Clinical Trials, Annals of Pharmacotherapy, vol.18, issue.7-8
DOI : 10.2165/00128413-199208520-00027

G. Velikova, D. Stark, and P. Selby, Quality of life instruments in oncology, European Journal of Cancer, vol.35, issue.11, pp.1571-1580, 1999.
DOI : 10.1016/S0959-8049(99)00193-8

N. Aaronson, M. Muller, P. Cohen, M. Essink-bot, M. Fekkes et al., Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations, Journal of Clinical Epidemiology, vol.51, issue.11, pp.1055-1068, 1998.
DOI : 10.1016/S0895-4356(98)00097-3

E. Eypasch, J. Williams, S. Wood-dauphinee, B. Ure, C. Schmulling et al., Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument, British Journal of Surgery, vol.340, issue.2
DOI : 10.1002/bjs.1800820229

G. Guyatt, C. Bombardier, and P. Tugwell, Measuring disease-specific quality of life in clinical trials, Cmaj, vol.134, pp.889-895, 1986.

M. Staquet, R. Berzon, D. Osoba, and D. Machin, Guidelines for reporting results of quality of life assessments in clinical trials, Quality of Life Research, vol.124, issue.5, pp.496-502, 1996.
DOI : 10.1007/BF00540022

K. Avery and J. Blazeby, Quality of Life Assessment in Surgical Oncology Trials, World Journal of Surgery, vol.92, issue.7, pp.1163-1172, 2006.
DOI : 10.1007/s00268-006-0075-8

F. Efficace, A. Bottomley, D. Osoba, C. Gotay, H. Flechtner et al., Beyond the Development of Health-Related Quality-of-Life (HRQOL) Measures: A Checklist for Evaluating HRQOL Outcomes in Cancer Clinical Trials???Does HRQOL Evaluation in Prostate Cancer Research Inform Clinical Decision Making?, Journal of Clinical Oncology, vol.21, issue.18, pp.3502-3511, 2003.
DOI : 10.1200/JCO.2003.12.121

F. Efficace and A. Bottomley, Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients, European Journal of Cancer, vol.38, issue.14, pp.1824-1831, 2002.
DOI : 10.1016/S0959-8049(02)00173-9

F. Efficace, A. Bottomley, G. Van-andel, A. Bottomley, F. Efficace et al., Health related quality of life in prostate carcinoma patients, Cancer, vol.162, issue.2, pp.377-3882982, 2002.
DOI : 10.1002/cncr.11065

P. Goodwin, J. Black, L. Bordeleau, and P. Ganz, Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock, JNCI Journal of the National Cancer Institute, vol.95, issue.4, pp.263-281, 2003.
DOI : 10.1093/jnci/95.4.263

F. Efficace, A. Bottomley, V. Vanvoorden, and J. Blazeby, Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials, European Journal of Cancer, vol.40, issue.2, pp.187-197, 2004.
DOI : 10.1016/j.ejca.2003.10.012

F. Efficace, G. Kemmler, M. Vignetti, F. Mandelli, S. Molica et al., Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials ??? A systematic review to evaluate the added value in supporting clinical decision making, European Journal of Cancer, vol.44, issue.11, pp.1497-1506, 2008.
DOI : 10.1016/j.ejca.2008.03.017

S. Gujral, K. Avery, and J. Blazeby, Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials, Supportive Care in Cancer, vol.11, issue.2, pp.127-132, 2008.
DOI : 10.1007/s00520-007-0356-2

D. Moher, A. Jones, and L. Lepage, Use of the CONSORT Statement and Quality of Reports of Randomized Trials, JAMA, vol.285, issue.15, pp.1992-1995, 2001.
DOI : 10.1001/jama.285.15.1992

A. Jadad, R. Moore, D. Carroll, C. Jenkinson, D. Reynolds et al., Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996.
DOI : 10.1016/0197-2456(95)00134-4

D. Moher, A. Jadad, and P. Tugwell, Abstract, International Journal of Technology Assessment in Health Care, vol.170, issue.02, pp.195-208, 1996.
DOI : 10.1001/jama.263.10.1401

P. Juni, D. Altman, and M. Egger, Systematic reviews in health care: Assessing the quality of controlled clinical trials, BMJ, vol.323, issue.7303, pp.42-46, 2001.
DOI : 10.1136/bmj.323.7303.42

C. Begg, M. Cho, S. Eastwood, R. Horton, D. Moher et al., Improving the Quality of Reporting of Randomized Controlled Trials, JAMA, vol.276, issue.8, pp.637-639, 1996.
DOI : 10.1001/jama.1996.03540080059030

D. Moher, K. Schulz, D. Altman, K. Avery, M. Sprangers et al., The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials Health-related quality of life measurement in randomized clinical trials in surgical oncology, Lancet Blazeby JM J Clin Oncol, vol.35724, issue.27, pp.1191-11943178, 2001.

F. Efficace, D. Osoba, C. Gotay, M. Sprangers, C. Coens et al., Has the quality of healthrelated quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making Interpreting the significance of changes in health-related quality-of-life scores Assessing meaningful change in quality of life over time: a users' guide for clinicians, Ann Oncol J Clin Oncol Mayo Clin Proc, vol.181677, issue.30, pp.775-781139, 1998.

A. Troxel, D. Fairclough, D. Curran, and E. Hahn, Statistical analysis of quality of life with missing data in cancer clinical trials, Statistics in Medicine, vol.17, issue.5-7, pp.653-666, 1998.
DOI : 10.1002/(SICI)1097-0258(19980315/15)17:5/7<653::AID-SIM812>3.0.CO;2-M

J. Bernhard, D. Cella, A. Coates, L. Fallowfield, P. Ganz et al., Missing quality of life data in cancer clinical trials: serious problems and challenges

T. Conroy, H. Bleiberg, and B. Glimelius, Quality of life in patients with advanced colorectal cancer, European Journal of Cancer, vol.39, issue.3, pp.287-294, 2003.
DOI : 10.1016/S0959-8049(02)00664-0

T. Young, H. De-haes, and D. Curran, Guidelines for Assessing Quality of Life in EORTC Clinical Trials

D. Osoba, A Taxonomy of the Uses of Health-Related Quality-of-Life Instruments in Cancer Care and the Clinical Meaningfulness of the Results, Medical Care, vol.40, issue.Supplement, pp.31-38, 2002.
DOI : 10.1097/00005650-200206001-00006